OD-07656
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for OD-07656, covering 2025-02-21 to 2026-02-11. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis [Phase 2]